Skip to main content

01.03.2018 | Arrhythmia (G Upadhyay, Section Editor) | Ausgabe 3/2018

Current Treatment Options in Cardiovascular Medicine 3/2018

Hybrid Epicardial-Endocardial Approach to Atrial Fibrillation Ablation

Current Treatment Options in Cardiovascular Medicine > Ausgabe 3/2018
MD Khola Tahir, MD Andy Kiser, MD Thomas Caranasos, MD, PhD J. Paul Mounsey, MD Anil Gehi
Wichtige Hinweise
This article is part of the Topical Collection on Arrhythmia


Who should undergo hybrid AF ablation?

Patients with symptomatic persistent or long-standing persistent atrial fibrillation refractory to pharmacological or routine catheter ablation can be considered for hybrid epicardial-endocardial AF ablation. Although it seems clear that patient selection should be important when considering hybrid AF ablation for optimal results, unfortunately, available data on the outcomes of hybrid epicardial-endocardial ablation is limited. Hybrid ablation is rarely compared to stand-alone catheter ablation, the surgical approach (access site, lesion set, ablation tool) is inconsistent, and the patient population studied is often suitable for a catheter ablation approach (paroxysmal AF, minimal structural heart disease). We believe that the hybrid approach should be considered in patients who either have had unsuccessful catheter ablations or have significant structural heart disease evident by enlarged left atrial size or atrial fibrosis. These are the patients who warrant the added risk of a hybrid approach and who stand to benefit from a more extensive ablation including isolation of the posterior wall of the left atrium. Multi-center studies with a uniform hybrid ablation approach and comparison with a stand-alone catheter ablation approach are needed to help clarify the role of hybrid AF ablation.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2018

Current Treatment Options in Cardiovascular Medicine 3/2018 Zur Ausgabe

Coronary Artery Disease (D Feldman and V Voudris, Section Editors)

Timing and Outcomes of PCI in the TAVR Era

Arrhythmia (G Upadhyay, Section Editor)

Permanent His Bundle Pacing for Cardiac Resynchronization

Arrhythmia (G Upadhyay, Section Editor)

Ablation Approaches for Ventricular Fibrillation

  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Kardiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.